Partial Meal Replacement and Inulin in Obese Women
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01505023|
Recruitment Status : Completed
First Posted : January 6, 2012
Last Update Posted : January 6, 2012
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Dietary Supplement: Partial meal replacement Dietary Supplement: Partial meal replacement with inulin Dietary Supplement: Inulin||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||179 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Evaluation of the Effectiveness of a Partial Meal Replacement With Inulin on Obesity and Dyslipidemias in Women.|
|Study Start Date :||April 2006|
|Actual Primary Completion Date :||November 2006|
|Actual Study Completion Date :||February 2007|
|Active Comparator: Partial meal replacement||
Dietary Supplement: Partial meal replacement
The PMR was designed to contain sufficient amounts of all vitamins and minerals. Women were instructed to consume 2 servings per day at breakfast and dinner, each consisting of 33 g of powder dissolved in 250 ml of skim milk.
|Experimental: Partial meal replacement with inulin||
Dietary Supplement: Partial meal replacement with inulin
The PMR was designed to contain sufficient amounts of all vitamins and minerals plus inulin. Women were instructed to consume 2 servings per day at breakfast and dinner, each consisting of 33 g of powder dissolved in 250 ml of skim milk.
|Active Comparator: Inulin||
Dietary Supplement: Inulin
Women were asked to consume one 5g serving of inulin mixed with any drink at breakfast and same amount at dinner (10 g of inulin/d).
|No Intervention: No intervention|
- Blood lipids
- Micronutrients intake
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01505023
|Universidad Autónoma de Querétaro|
|Querétaro, Mexico, 76230|